Marco Marchetti has a diverse work experience spanning several industries. Marco is currently the Chief Executive Officer and Co-Founder of FB Dermatology, a role they have held since January 2020. Prior to that, they served as the Executive Chairman and Co-Founder of FB VISION, a company focused on eye health products, from January 2016 to March 2022.
In addition, Marchetti also co-founded LONGEVA HEALTH in January 2020 and served as its Chief Executive Officer and Co-Founder until March 2021. LONGEVA HEALTH is dedicated to research, development, and commercialization of innovative solutions for Healthy Aging.
Before their involvement with FB Dermatology, FB VISION, and LONGEVA HEALTH, Marchetti co-founded and served as the Managing Director of Neuraxpharm Italy from September 2010 to September 2019. Neuraxpharm primarily focused on the research, development, and marketing of pharmaceutical and nutraceutical products for the prevention and treatment of diseases affecting the Central Nervous System.
Prior to Neuraxpharm, Marchetti held various positions in the healthcare industry. Marco was a Member of the Board of Directors at Kleresca / FB Dermatology from January 2017 to August 2019. Marco also served as the Director of European Operations at Bellus Health from January 2009 to December 2010. Additionally, Marchetti worked as the Director of Business Development at KLOX Technologies from 2009 to 2010.
Marchetti's earlier experience includes a role as the Marketing Director at OOGroup - Ophthalmic Pharmaceutical Group from January 2003 to December 2008. In this position, they were responsible for developing and implementing marketing strategies and communications both nationally and internationally.
Throughout their career, Marchetti has demonstrated their expertise in the healthcare industry, particularly in areas such as dermatology, eye health, healthy aging, and pharmaceuticals. Marco has shown a strong entrepreneurial spirit, co-founding multiple companies, and holding executive positions.
Marco Marchetti's education history includes earning an MBA from Luiss Guido Carli University from 2000 to 2001. Prior to that, they completed an MsC in Biotechnology from Alma Mater Studiorum – Università di Bologna from 1995 to 2000.
Sign up to view 1 direct report
Get started
This person is not in any teams